1. CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease. (6th January 2021) Authors: Teh, Yoong Mond; Lim, Soo Kun; Jusoh, Norhana; Osman, Kahar; Mualif, Siti Aisyah Other Names: Abu Shahin Nisreen Academic Editor. Journal: BioMed research international Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD80 Insights as Therapeutic Target in the Current and Future Treatment Options of Frequent-Relapse Minimal Change Disease. (6th January 2021) Authors: Teh, Yoong Mond; Lim, Soo Kun; Jusoh, Norhana; Osman, Kahar; Mualif, Siti Aisyah Other Names: Abu Shahin Nisreen Academic Editor. Journal: BioMed research international Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Safety of Roxadustat in Patients with Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials including 6, 518 Patients. (14th November 2022) Authors: Lei, Juanjuan; Li, Han; Wang, Shixiang Other Names: Abu Shahin Nisreen Academic Editor. Journal: BioMed research international Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ginkgo Biloba Extract EGB761 Ameliorates the Extracellular Matrix Accumulation and Mesenchymal Transformation of Renal Tubules in Diabetic Kidney Disease by Inhibiting Endoplasmic Reticulum Stress. (23rd March 2021) Authors: Han, Jiarui; Pang, Xinxin; Shi, Xiujie; Zhang, Yage; Peng, Zining; Xing, Yufeng Other Names: Abu Shahin Nisreen Academic Editor. Journal: BioMed research international Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗